Shenzhen, China, 10 April 2024 — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technology to lead life sciences, proudly announces its recognition by Global Health & Pharma (GHP) Magazine’s Biotechnology Awards 2024 as the Most Innovative Next-Gen Sequencing Company.
“We are honoured to be named the Most Innovative Next-Gen Sequencing Company,” said Duncan Yu, President of MGI. “Next-generation sequencing (NGS) has transformed genomics research and its application in healthcare across various fields, driving the utilisation of genomics for the betterment of humanity. MGI remains committed to providing comprehensive, real-time solutions for diverse genetic sequencing needs.”
Global Health & Pharma Magazine (GHP) serves as a vital information hub for the healthcare and pharmaceutical industries. With a global circulation of 110,000, the UK-based magazine holds deep respect for the ground-breaking research and intellect within the biotechnology sector. The annual Biotechnology Awards recognise companies at the forefront of innovation, driving progress in biotechnology.
Established in 2016, MGI operates in over 100 countries and has facilitated the publication of more than 6,200 studies spanning diverse applications. As one of the few companies capable of independently developing and mass-producing medium- to high-throughput clinical gene sequencers, ranging from gigabytes to terabytes, MGI has established itself as a prominent organisation in the industry. Committed to advancing human health, MGI continuously pioneers cutting-edge sequencing technologies to support the healthcare sector in achieving its goals.
Kaven Cooper, Awards Coordinator for the Biotechnology Awards 2024, commented on MGI’s success, stating, “MGI’s relentless pursuit of revolutionary systems and gene sequencing products demonstrates its ability to drive positive change in global healthcare sectors. We eagerly anticipate the continued impact of MGI’s innovations. Congratulations to MGI Tech on its dedication to driving change, and we look forward to witnessing its continued success throughout 2024 and beyond.”
